MIM
SCMP

MetLife Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

MetLife Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,005
Closed -$215K – 2255
2017
Q4 		$215K Buy
+12,005
New +$148K ﹤0.01% 1887

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

MetLife Investment Management's SCMP Position: Q1 2018 in Review

MetLife Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 12,005 shares — an estimated $215K sold.

MetLife Investment Management first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $215K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • MetLife Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • MetLife Investment Management sold 12,005 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $215K.
  • MetLife Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • MetLife Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $215K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on MetLife Investment Management's 13F filing for Q1 2018, filed 15 May 2018.